A cross-sectional and longitudinal evaluation of serum creatinine as a biomarker in spinal muscular atrophy

A cross-sectional and longitudinal evaluation of serum creatinine as a biomarker in spinal muscular atrophy

Abstract Objective Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by proximal muscle weakness and atrophy. The increasing availability of disease-modifying therapies has prompted the development of biomarkers to facilitate clinical assessments. We explore...

Full description

Bibliographic Details
Main Authors: Xin Zhao, Zhenxiang Gong, Han Luo, Zehui Li, Rong Gao, Kangqin Yang, Wenhua Deng, Sirui Peng, Li Ba, Yang Liu, Min Zhang
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Spinal muscular atrophy
Creatinine
Biomarkers
Nusinersen
Online Access:https://doi.org/10.1186/s13023-024-03515-0

Internet

https://doi.org/10.1186/s13023-024-03515-0

Similar Items